GLORIA-AF Final Phase II Two-year safety and Effectiveness of Dabigatran in AF Patients (GYH Lip)

Summary of GLORIA-AF Final Phase II: Two-year safety and effectiveness of dabigatran in patients with atrial fibrillation (summarized by Prof Gregory Lip). An educational video summarizing data presented at EHRA, Barcelona 2018.

LEAVE YOUR COMMENT

Your email address will not be published.